Physician
Dermatology
David Pascoe works in the field of Dermatology. He went to medical school at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He over the years received 1 awards: "Fellow (FAAD)". Dr. David Pascoe is registered with Medicare and accepts Medicare payments.
Schools
Duke University School Of Medicine
Procedures Preformed
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Malignant Skin Lesion
Conditions Treated
- Acne
- Actinic Keratosis
- Athlete's Foot
- Basal Cell Carcinoma
- View All
Doctors Specialties
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Select
- BlueDental Choice
- NetworkBlue
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare
- CoreSource
- Employer Group Open Access HMO
- Employer Group PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- POMCO Group
- Principal Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
Awards
Education
-
University of North Carolina Hospitals
-
Duke University School of Medicine
Drug Facts
NPI NUMBER |
|
1003038555 |
NPPES Provider LastName |
|
PASCOE |
NPPES Provider FirstName |
|
DAVID |
NPPES Provider ZIPCode |
|
323084453 |
NPPES Provider State |
|
FL |
Specialty Description |
|
Dermatology |
Total Claim Count |
|
635.0 |
Distinct Opioid Count |
|
0.0 |
Opioid Claim Count |
|
0.0 |
Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1003038555 |
Last Name Of The Provider |
PASCOE |
First Name Of The Provider |
DAVID |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog